Digital Diabetes Self Management Education and Support for Patients With Type 2 Diabetes
NCT ID: NCT05026528
Last Updated: 2021-12-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
300 participants
INTERVENTIONAL
2021-11-30
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Digital DSME/S
Ten-week intervention during which the participant uses a digital diabetes self management education and support system together with the diabetes nurse.
Digital diabetes self management education and support system
Digital diabetes self management and support system
Standard care
Control group continuing with regular standardized care.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Digital diabetes self management education and support system
Digital diabetes self management and support system
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fasting plasma glucose \> 7 mmol/L at two timepoints. OR
* HbA1c ≥ 48 mmol/mol twice or in combination with fasting plasma glucose \> 7 mmo/L once. OR
* Non-fasting plasma glucose ≥ 11.1 mmol/L at one timepoint in combination with symptoms of hyperglycemia.
* Access to a digital ID-card to access the digital system
* Access to a computer, tablet or smart phone
* Sufficient knowledge of written and spoken Swedish to understand the information given in the digital system.
Exclusion Criteria
* Other co-morbidities limiting the use of the digital system according to the diabetes nurse judgement. E.g. dementia or severe psychiatric disease.
* Other forms of diabetes mellitus than type 2 diabetes.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Linkoeping University
OTHER_GOV
Region Östergötland
OTHER
Uppsala County Council, Sweden
OTHER_GOV
The Swedish Diabetes Foundation
UNKNOWN
Medical Research Council of Southeast Sweden
OTHER_GOV
Region Jönköping County
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andreas Stomby, MD/PhD
Role: PRINCIPAL_INVESTIGATOR
Region Jönköping County and Linköping University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wetterhälsan
Jönköping, , Sweden
Aroma Vårdcentral
Vetlanda, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Anders Tengblad, PhD
Role: primary
Johanna Richter
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Bra liv med diabetes typ 2
Identifier Type: -
Identifier Source: org_study_id